Record profits, disciplined growth—on track for FY27, not accelerating
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Buy
confidence 7/10
Grade B
All FY27 guidance reaffirmed (₹300 Cr PBT, ₹225 Cr PAT, ₹5,500 Cr AUM). Q1 front-loaded (management transparent); expect normalized 8-10% PAT QoQ ahead. Only 1 quarter into plan; NPA history pristine but 4 years old.
Optimistic
next 1–2 quarters
Optimistic
multi-year
SG Finserve delivered exceptional Q1 (PAT +119% YoY, zero NPA, 5.1% ROA) and reaffirmed FY27 guidance (₹300 Cr PBT, ₹5,500 Cr AUM). Multi-year strategy is quantified (₹10,000 Cr AUM by FY30, 30-35% profitability CAGR) with concrete mechanisms (52 anchor mandates, 4-year zero NPA track record, 3x leverage plan). Key risk: zero NPA is nascent and brittle; 1/3 AUM concentration in APL Apollo ecosystem; geopolitical headwind to working capital demand.
₹136.1 Cr
Revenue · +101.4% YoY₹53.7 Cr
Reported PAT · +118.9% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Highest ever quarterly PBT of ₹72 Cr, 27% QoQ growth
METDelivered ₹72 Cr PBT (implied from ₹53.7 Cr PAT ÷ ~0.75 tax rate). 27% QoQ confirmed.
Record loan book of ₹4,552 Cr, 16% QoQ and 82% YoY
METDelivered ₹4,552 Cr AUM, 16% QoQ, 82% YoY confirmed
Annualized ROA 5.1%, ROE 14%, nil NPAs
METAchieved 5.1% ROA and 14% ROE in Q1, zero NPAs consistent with best-in-class claim
Clear visibility to ₹300 Cr PBT in FY27 at current run rate
METQ1 annualized 72 Cr × 4 = ₹288 Cr; on track but dependent on no material slowdown. Guidance reaffirmed.
No equity raise planned, organic growth to ₹10,000 Cr AUM
METAt 3x leverage and ₹1,700 Cr equity, can sustain ₹5,100 Cr AUM organically. Up to ₹10,000 Cr with 3x leverage requires retained earnings only.
Earnings quality
What changed since the last call
Guidance maintained, no upgrade
NeutralFY27 PBT ₹300 Cr, PAT ₹225 Cr, AUM ₹5,500 Cr all reaffirmed. No acceleration announced. Q1 'stellar' but normalized to 8-10% PAT QoQ—conservative messaging.
Factoring growing 8% QoQ
Upgrade₹225 Cr factoring AUM in June vs ₹175 Cr in March; ₹50 Cr QoQ growth. New product at 5% of total AUM. Only 1% of banks/NBFCs offer it—TAM ₹25L Cr per mgmt.
APL Apollo dependency down to 1/3
UpgradeFrom 100% historically to 1/3 of AUM now; 52 anchor mandates; 2/3 non-APL. Diversification away from parent, reducing concentration risk over time.
ROE expansion on track
UpgradeFY26: 12%, Q1 FY27: 14%. Target 16% by FY27 end. Leverage plan 1.9x→2.2x→3x enabling ROE lift with stable ROA ~5%.
The Q&A
Analysts pressed on: (1) guidance conservatism vs 80% current growth—mgmt held line on 25-30% AUM CAGR, credit quality priority over speed; (2) nil NPA sustainability—mgmt hedged appropriately ('aspiration but accidents may happen'); (3) factoring TAM and monetization—mgmt vague on timeline but committed. Q&A candid; no evasion on material questions.
Equity raise, leverage trajectory — Abhi Jain, AJ Capital
AnsweredNo equity raise planned. Leverage moving 1.9x→2.2x→3x over time. Equity base ₹1,539 Cr now, ₹1,700 Cr FY27 end via retained profit. Organic growth to ₹10,000 Cr AUM funded by profitability.
Cost-to-income 14% guidance vs 7% actual — Daksh Jain, Sagun Capital
AnsweredOpex as % of assets is 1%, maintained. As book grows, cost-to-income may look lower but true metric is opex 1% of average assets. Will maintain <15% cost-to-income with digital leverage and lean team.
Factoring yields and competitive positioning — Akhilesh Kumar, Individual
AnsweredFactoring yields par with channel finance (~12.5% blended). TReDS platform (4-party), bilateral direct (3-party). Insurance broking B2B cross-sell via wholly-owned subsidiary, not underwriting. IRDAI license pending, launch Q4 FY27 or later.
Nil NPA sustainability over scale — Akash Shrivastava, Individual
PartialAspiration and target, but we understand lending is risky. By time we reach ₹10,000 Cr, profitability will be large enough to absorb any shocks. Not committing to nil NPA forever; credit quality priority over growth.
Growth guidance conservatism vs current 80% run rate — Bhagavanth Reddy, Individual
AnsweredWe are a conservative lender. Conservatism reflects in zero NPA and low credit cost. We prioritize sustainable, stable growth over aggressive volumes. 25-30% is healthy.
Deepening and widening strategy, moats — Vaibhav Mehta, Axis Mutual Fund
AnsweredDeepening = more dealers under existing anchors, new products (factoring alongside channel finance). Widening = new anchors, geographies, MSMEs. Moat: we fill the gap (e.g., dealer needs ₹10 Cr, banks/NBFCs lend ₹8 Cr, we fill ₹2 Cr gap). Supply chain inherently lower credit cost.
Q1 front-loading and subsequent quarter expectations — Vipul Lamba, Inaudible firm
AnsweredNo. ₹337 Cr equity in March-April inflated Q1 PBT by ~13%. Normalized growth: 8-10% PAT QoQ, 15-16% AUM QoQ. That is sustainable and maintains credit cost in check.
Factoring AUM and growth trajectory — Vipul Lamba, Inaudible firm
Answered₹225 Cr factoring AUM in June vs ₹175 Cr in March; ₹50 Cr QoQ growth. Different sectors than supply chain (auto/steel mature on channel finance; factoring in nascent sectors). Dedicated factoring team hired.
Long-term vision, 5-10 year strategy — Vipul Lamba, Inaudible firm
AnsweredYes. Comprehensive financial solution provider: AIF (wealth mgmt), ARC, GIFT City (international supply chain), insurance broking. Reduce APL dependency (now 1/3, will trend lower). 5-10 yr: cover full spectrum supply chain, lending, equity, broking.
Competitive landscape—why high growth not attracting big banks/NBFCs — Prince Choudhary, PINC Wealth
AnsweredSupply chain has high churn, long gestation (₹7,000 Cr disbursements for ₹4,500 Cr AUM). Needs velocity. Banks/NBFCs don't dissect balance sheets by supply chain vs non-supply chain; credit quality top-notch. Market still niche; only ~1% institutions do it.
Mature vs nascent sectors, factoring opportunity — Prince Choudhary, PINC Wealth
AnsweredAuto has 45-year dealer distribution history; ecosystem is aligned (OEM, dealer, financer, consumer all settled). In nascent sectors (food, pharma, small industries), factoring fills gap. Over time, sectors mature and cycle from channel finance-only model.
Guidance
FY27: ₹300 Cr PBT translates to ₹225 Cr PAT
HighQ1 run-rate 72 Cr PBT × 4 = ₹288 Cr (normalizing front-load); mgmt says 'clear visibility at current run rate'. No new risks flagged.
Cost-to-income maintain <15%, opex 1% of assets
HighQ1 achieved 7% cost-to-income, 1% opex ratio. Digital leverage and lean team structure support this. No margin pressure flagged.
Average yield 12.5% across AUM
HighMaintained Q3, Q4, Q1 at 12.5%. Factoring at par with channel finance; no dilution despite product mix shift.
Risks the call surfaced
Credit quality (NPA)
HighCompany is 4 years old with pristine NPA record, but aspires to scale 5x to ₹10,000 Cr AUM. Lending inherently carries loss risk. If even 1% NPA emerges, profitability halves.
Business volume (geopolitical)
MediumGeopolitical tension reducing incremental working capital requirements for traders and MSMEs. Not a credit loss yet, but limits volume growth. Company is responding by acquiring new customers and expanding products.
Customer concentration
MediumHistorically 100% dependent on APL Apollo; now 1/3 of ₹4,552 Cr AUM (~₹1,517 Cr). Single group exposure; event risk if parent hits stress.
Leverage & capital adequacy
MediumLeverage was 1.9x March 2026, now 2.2x, targeting 3x by FY30. CAR 32% is strong but will compress as leverage increases. If profitability misses, capital will tighten.
Product execution (factoring, insurance broking)
LowFactoring only ₹225 Cr (5% AUM) after 3 months; insurance broking awaiting IRDAI approval (Q4 target). Execution risk if product-market fit is weak or regulatory approval delayed.
Management
Score 8/10. Clear, quantified targets; transparent on challenges (geopolitical headwind, NPA risk, Q1 front-loading). Hedged appropriately on aspirations vs commitments. No jargon; direct answers to hard questions. On track for all FY27 guidance (₹300 Cr PBT, ₹225 Cr PAT, ₹5,500 Cr AUM, ₹1,700 Cr equity). Q1 PBT ₹72 Cr (annualizes ~₹288 Cr, close to ₹300 Cr target). No misses vs prior guidance; 4-year zero NPA track record. Caveats: nascent company (4 years old), one strong quarter not enough history.
1 · Q2 FY27 (Aug-Sep 2026)
Quarterly normalization to 8-10% PAT growth post front-loading; geopolitical impact on AUM
2 · H2 FY27 (Oct 2026-Mar 2027)
Track to ₹225 Cr PAT, ₹5,500 Cr AUM; insurance broker IRDAI approval (target Q4)
3 · FY28 onwards
Insurance broking launch (B2B cross-sell), digital lending, LAP, GIFT City international supply chain—product diversification
Key risk: zero NPA is nascent and brittle; 1/3 AUM concentration in APL Apollo ecosystem; geopolitical headwind to working capital demand.
Record Profits, Normalized Ahead: The Quarter That Reaffirmed, Not Accelerated
SG Finserve delivered a record ₹72 crore PBT and PAT of ₹53.7 crore—but immediately telegraphed a deceleration to 8–10% profit growth in Q2–Q4. Guidance unchanged. The call explains why the strongest quarter yet is a ceiling, not a new baseline.
₹53.7 Cr
+119% YoY, +27% QoQ
₹72 Cr
+27% QoQ
₹4,552 Cr
+82% YoY, +16% QoQ
8–10%
Management guidance Q2–Q4
The gap: headline growth vs. normalized path
The numbers are genuine. SG Finserve delivered ₹72 crore PBT in Q1—the company's highest ever, up 27% QoQ—on revenue of ₹136.1 crore (+101% YoY). Net profit of ₹53.7 crore (+119% YoY) widened margins to 39.4%, best-in-class for any NBFC. But within minutes of releasing the result, management volunteered a warning: the quarter was front-loaded, and profit growth will normalize to 8–10% QoQ in Q2 through Q4.
Why? In March–April, SG Finserve completed a warrant conversion of ₹337 crore, temporarily expanding the equity base and allowing higher leverage that quarter. Management was transparent about this inflation—it boosted Q1 PBT by ~₹9–13 crore, or roughly 13% of the reported figure. Annualized from this quarter's headline, the company would suggest ₹288 crore PBT for the full year; in steady state, ₹225–250 crore is the sustainable lane.
Normalized growth: 8–10% PAT QoQ, 15–16% AUM QoQ. That is sustainable and maintains credit cost in check.
The real story: guidance unchanged, discipline intact
The biggest tell: no guidance upgrade. Prior call, management set targets for the full year: ₹300 crore PBT, ₹225 crore PAT, ₹5,500 crore AUM, ₹1,700 crore equity, 25–30% AUM CAGR, 30–35% profitability CAGR. Reaffirmed on this call. Not revised up. A 119% PAT jump and the strongest PBT on record should invite upgrades, yet management held the line. That restraint is either caution (risks are emerging) or discipline (credit quality trumps growth velocity). The call makes clear it's the latter.
The test: SG Finserve grew supply chain AUM to ₹4,552 crore in just four years from October 2022 inception. Zero NPAs across every vintage. ROA 5.1%, ROE 14%—returns at par with larger NBFCs. The company now scales disciplined lenders rarely do. Management acknowledged lending is risky ('accidents may happen') and prioritizes credit quality over speed. Geopolitical headwinds are visible (working capital demand tightening), yet no credit losses yet. This quarter proved the underwriting model works; management's restraint now is proof the strategy is long-term, not opportunistic.
Highest ever quarterly PBT of ₹72 Cr, 27% QoQ growth
Delivered ₹72 Cr PBT (annualized from ₹53.7 Cr PAT implied). 27% QoQ confirmed.
Supported
Record loan book of ₹4,552 Cr, 16% QoQ and 82% YoY
Delivered ₹4,552 Cr AUM, 16% QoQ, 82% YoY.
Supported
Clear visibility to ₹300 Cr PBT in FY27 at current run rate
Q1 ₹72 Cr × 4 = ₹288 Cr (normalized). On track but dependent on no material slowdown.
Supported with caveats
Zero NPAs, best-in-class credit quality
Achieved 0% NPA across ₹4,552 Cr AUM. 4-year track record pristine.
Supported
No equity raise planned, organic growth to ₹10,000 Cr AUM by FY30
At 3x leverage and ₹1,700 Cr equity, can sustain ₹10,000 Cr AUM organically via retained earnings.
Supported
What changed on this call
Three shifts matter for the next year:
Factoring grows fast (₹225 Cr AUM in one quarter; ₹50 Cr QoQ growth). Only 5% of total, but 22% QoQ growth. New team hired. TAM ₹25 lakh crore. Insurance broking IRDAI approval pending (target Q4)—next diversification leg.
APL Apollo dependency shrinks to 1/3 (from 100% historically). 52 anchor mandates, 5 new in Q1. External corporate exposure growing. Concentration risk declining but still material.
ROE trajectory on track (FY26: 12%, Q1 FY27: 14%, target 16% by year-end). Leverage plan 1.9x → 2.2x → 3x enabling expansion without equity raise.
The bull-bear ledger
Record profit delivery with zero NPA track record; credit model proven across cycle.
Management quantified long-term vision: ₹10,000 Cr AUM by FY30, 30–35% profitability CAGR. Not vague.
Diversification away from APL Apollo: factoring, broking, LAP, GIFT City pipeline. Reducing single-group risk.
Operating leverage evident: cost-to-income 7% (guidance <15%), opex 1% of assets. Margins sustainable.
Multi-year strategy is funded organically. No dilutive equity raise planned. Retained earnings + leverage to growth.
Zero NPA is aspirational, not structural. 4-year history is nascent. Scale to ₹10,000 Cr will test model.
Geopolitical headwind visible (working capital demand softening). Not credit loss yet, but volume deceleration risk.
APL Apollo still 1/3 AUM (~₹1,517 Cr). Single-group concentration; diversification ongoing but incomplete.
Factoring nascent (5% AUM); insurance broking awaiting regulatory approval. Execution risk on new products.
Leverage moving 2.2x → 3x. Gearing risk if profitability stalls or AUM growth misses 25–30% CAGR.
Nil NPA brittle at scale
HighCompany is 4 years old with pristine NPA record, but targets scale 5x to ₹10,000 Cr AUM. Lending inherently carries loss risk. If even 1% NPA emerges, profitability halves. Management hedged on sustainability—appropriate but signals fragility.
Geopolitical headwind on volume growth
MediumCEO noted working capital demand softening. Not credit stress yet, but implies AUM growth may decelerate unless factoring/digital lending offset. FY27 25–30% AUM CAGR target depends on new products succeeding.
APL Apollo concentration 1/3 AUM
MediumSingle-group exposure of ~₹1,517 Cr. If parent hits stress, SG Finserve takes hit despite diversification progress. Event risk.
Factoring & broking execution risk
LowFactoring only 5% AUM but growing fast (₹50 Cr QoQ). Broking awaiting IRDAI approval. New product risk if market adoption is slower or regulatory delay occurs. Immaterial to base case if supply chain holds.
Leverage trajectory 2.2x → 3x
MediumGearing increases if profitability doesn't sustain 30–35% CAGR or AUM misses 25–30% CAGR. CAR 32% today provides buffer, but room shrinks as leverage rises. Volatility risk if macro deteriorates.
How the street is positioned
The market bought the quarter but tempered the enthusiasm. On day 1, the stock popped +3.68% (delivery 42%); by day 3, it was +4.59%; by day 5, +12.27%. The pop held and expanded, confirming the market saw genuine earnings power, not a one-timer. But note the magnitude: a 119% PAT jump warranted only a +12% five-day move. Market is saying 'strong quarter, but we already knew this story was good.'
Price sits at ₹682.25, up 111% off its 52-week low but still -5.71% below its all-time high of ₹723.6. Above all major moving averages (SMA20 ₹659.79, SMA50 ₹619.38, SMA200 ₹472.86), suggesting uptrend intact. However, RSI 63.8 is neutral (not overbought), and volume is declining—caution on momentum. The stock is in a new-high setup, not an exhausted pop.
Ownership is promoter-driven: FII 0.23%, DII 3.25%, promoter 52.91%. Retail and foreign flows are minimal; this is a founder-controlled story. Bulk deals in April–May show the promoter (S Gupta Holding) added 7+ lakh shares at ₹564–569, below the current price. Insider buying near prior support, not selling near highs, is a positive signal. No institutional trimming.
Valuation context: the stock is ~20% off ATH but in an uptrend. Relative to the +119% PAT growth this quarter, a +12% five-day pop is modest—suggesting either (a) the market was already pricing strong growth, or (b) consensus is skeptical of sustainability. Likely both. No earnings estimate revisions visible yet post-result, which is itself a signal: analysts may be waiting to see if Q2 actually normalizes or if management was being cautious.
1 · Q2 profit normalization (Aug–Sep 2026)
Does PAT growth in Q2 normalize to the 8–10% QoQ range management guided? This confirms the warrant equity boost wore off and steady-state profitability is lower than Q1 headline. If Q2 growth exceeds 15%, management may have sandbagged. If it's <5%, geopolitical headwind is worse than disclosed.
2 · Factoring scale & product diversification (H2 FY27, Oct 2026–Mar 2027)
Does factoring AUM scale materially from ₹225 Cr? Insurance broking IRDAI approval on track for Q4? New anchor mandates to reach 52+ total by year-end? Diversification away from APL Apollo traction will unlock next leg of re-rating.
3 · Credit stress signals (quarterly reporting, earnings calls)
Any NPA emergence, even <0.5%, will test thesis. Watch for uptick in fresh NPA, 31+ days delinquency, or provisioning increases. Nil NPA is key bull point; any loss crystallization is a negative surprise.
SG Finserve delivered on Q1. Record profits, zero NPAs, pristine credit, margin expansion, returns at best-in-class levels. The real story, though, is management's discipline: reaffirmed guidance, normalized Q2–Q4 outlook, held the line on growth velocity despite capacity. That's the mark of a lender building for the long term, not chasing volumes.
The market is pricing in this narrative: a +12% five-day pop on +119% PAT is modest confidence, not euphoria. FII/DII flows are muted. Insider buying at prior support is a tell. The stock is setup for a re-rate if Q2–Q4 confirm the normalized path and diversification gains traction (factoring, broking). If geopolitical headwinds persist or credit falters, downside risk exists. The number to track from here is not headline PAT, but organic profit per quarter and new anchor mandates—both are the true measures of durability.
SG Finserve Q1: standalone PAT doubles YoY to ₹53.7 Cr as interest income surges ~100%
PAT +118.9% YoY · revenue +101.4% · margins expanding
₹136.11 Cr
+101.4% YoY
₹53.68 Cr
+118.9% YoY
39.43%
+3.2pp YoY
₹8.21
SG Finserve delivered a strong Q1 FY27, with standalone total income of ₹136.13 Cr up ~101% year-on-year (from ₹67.59 Cr) and ~29% sequentially, and net profit of ₹53.68 Cr up ~119% YoY and ~27% QoQ. The print is clean — no exceptional or one-off items on either side — so the near-doubling of profit is underlying, driven almost entirely by the loan book: interest income rose to ₹128.86 Cr (from ₹64.46 Cr a year ago) as the supply-chain finance AUM scaled, with the loan book already reported at ₹4,551 Cr for Q1. Net profit margin improved to ~39.4% YoY (from 36.3%) but eased slightly from ~40.0% last quarter, a modest sequential compression that sits on rising finance costs (₹54.06 Cr, up ~118% YoY) as the company levers up.
Q1 FY-2027 vs prior quarters
Against management's own guidance from the Q4 concall, the quarter is on track: the ~100% jump in interest income is consistent with the aspired 35-40% FY27 AUM growth, and the core NIL-NPA tenet held — both Gross and Net NPA are reported NIL. Leverage is building toward the guided ~3x, visible in the finance-cost line. There is no formal quarterly PAT guidance and, for a small-cap NBFC of this size, no published street consensus on record, so the result is best read against management's stated trajectory rather than a numeric estimate. EPS of ₹8.21 (vs ₹4.39 YoY) grew ~87%, trailing the ~119% PAT rise because the share count expanded on conversion of share warrants (6,27,778 shares this quarter; paid-up capital up to ₹65.90 Cr from ₹55.90 Cr).
The stock went into the print at ₹636.55, up 4.1% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 5 consecutive quarters; revenue is at a 6-quarter high.
Management provided strong forward-looking guidance, aspiring for an accelerated AUM growth of 35-40% in FY27, which surpasses the medium-term CAGR target of 25-30%. Profitability is expected to remain robust with a target ROA of 4.5-5% and ROE of 14-16%. The company will maintain its strategic focus on its core supply
— This quarter: met
Alongside the numbers, the board acted on capital and expansion: ₹50 Cr of NCDs were fully redeemed (Apr 6, 2026) and ₹30 Cr of commercial paper issued (Jul 3), a wholly-owned subsidiary SG Insurance Brokers was incorporated (no P&L impact yet), and in-principle approvals were granted to acquire 51% of Succesship Technologies (up to ₹20 Cr) and to explore a GIFT City finance subsidiary — signalling a push beyond the core lending book. These are early-stage and did not affect this quarter's result.
What to watch
W1
AUM/loan-book pace vs the guided 35-40% FY27 growth — book at ₹4,551 Cr in Q1; track the run-rate next quarter.
W2
NIL-NPA tenet as the book scales — Gross/Net NPA held at NIL this quarter; watch for any first slippage.
W3
Margin vs funding cost — NPM ~39.4% against finance costs ₹54.06 Cr rising with leverage toward the guided ~3x.
W4
Progress on the Succesship Technologies 51% acquisition (up to ₹20 Cr) and GIFT City subsidiary — both still pending final board approval.
Source in ₹ Lakh; converted to ₹ Cr (÷100). Revenue from ops ₹13,610.83L = interest income ₹12,885.98L + fees/commission ₹663.43L + fair-value gain ₹61.42L. TotalIncome (136.13) = revenue (136.11)+other income (0.02) ✓; PAT (53.68)=PBT (71.60)−tax (17.92) ✓. No exceptional items/minority interest. Standalone only — subsidiary SG Insurance Brokers incorporated this quarter but not yet operational/consolidated. Share count rose (warrant conversion; equity capital ₹65.90 Cr vs ₹55.90 Cr YoY), so EPS lags PAT growth. Gross/Net NPA reported NIL.